Annexon Biosciences (ANNX)
US Market

Annexon Biosciences (ANNX) Financial Statements


Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently ―. The company's EPS TTM is $-1.46; its P/E ratio is -4.02; Annexon Biosciences is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 1.60M$ 600.00K$ 600.00K$ 400.00K
Gross Profit-$ 400.00K$ 600.00K$ 600.00K$ 400.00K
EBIT$ -28.57M$ -30.01M$ -34.78M$ -37.69M$ -41.24M
EBITDA$ -28.03M$ -29.47M$ -34.55M$ 0.00-
Net Income Common Stockholders$ -25.18M$ -27.89M$ -32.48M$ -35.19M$ -38.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 264.95M$ 259.72M$ 165.27M$ 192.94M$ 228.16M
Total Assets$ 304.07M$ 297.67M$ 203.82M$ 233.01M$ 268.78M
Total Debt$ 30.79M$ 31.36M$ 31.51M$ 32.01M$ 32.51M
Net Debt$ -234.16M$ -228.36M$ -133.76M$ -160.92M$ -195.66M
Total Liabilities$ 41.66M$ 47.12M$ 46.98M$ 48.29M$ 53.92M
Stockholders Equity$ 262.38M$ 250.56M$ 156.84M$ 184.75M$ 214.86M
Cash Flow-
Free Cash Flow$ -28.27M$ -23.48M$ -28.31M--
Operating Cash Flow$ -28.27M$ -23.48M$ -28.29M--
Investing Cash Flow$ -77.30M$ -2.18M$ 47.84M--
Financing Cash Flow$ 32.41M$ 117.60M---
Currency in USD

Annexon Biosciences Earnings and Revenue History

Annexon Biosciences Debt to Assets

Annexon Biosciences Cash Flow

Annexon Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis